logo

Stock Screener

Forex Screener

Crypto Screener

SYRA

Syra Health Corp. Class A Common Stock (SYRA)

$

0.1


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

-0.1708

Market cap

Market cap

1.1 Million

Price to sales ratio

Price to sales ratio

0.1413

Debt to equity

Debt to equity

0.0528

Current ratio

Current ratio

2.8811

Income quality

Income quality

0.7086

Average inventory

Average inventory

0

ROE

ROE

-1.0353



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Syra Health Corp., a prominent healthcare services company, operates within the United States, focusing on various essential sectors such as health education, population health management, behavioral and mental health, healthcare workforce, and digital health services. The weighted average number of shares outstanding is 7,264,768.00 highlighting the company's shareholder base and its engagement within the financial market. Additionally, the weighted average number of diluted shares outstanding stands at 7,264,768.00 reflecting the potential dilution effects that may impact shareholders. The company has incurred an interest expense of $15,600.00 which underscores its debt servicing obligations and the financial responsibilities it maintains. Syra Health Corp.'s stock is identified with the symbol 'SYRA' in the market, allowing investors to track its performance. The net income ratio is -0.47 reflecting the company's profitability margin while demonstrating its operational effectiveness and ability to generate profits in a competitive landscape. Apart from these financial metrics, Syra Health Corp. is also known for its significant offerings including health education services such as medical communications and patient education, along with population health management services like analytics as a service and health equity analytics solutions. The development of Syrenity, an on-demand telehealth platform for mental health services, exemplifies the company's commitment to innovation, while it also provides healthcare staffing solutions and digital health advancements focused on areas like artificial intelligence and patient engagement. In the current market, the stock is affordable at $0.10 making it suitable for budget-conscious investors eager to engage with a promising company. However, it is important to note that the stock has a low average trading volume of 283,651.00 indicating lower market activity and potentially higher volatility. With a market capitalization of $1,146,163.00 the company is classified as a small-cap player, representing a unique opportunity for growth within this segment. Syra Health Corp. stands out as a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and driving innovation and growth. Furthermore, it belongs to the Healthcare sector, where continued advancements and developments are vital for fostering a healthier and more efficient healthcare system.

What is Syra Health Corp. Class A Common Stock (SYRA)'s current stock price?

The current stock price of Syra Health Corp. Class A Common Stock (SYRA) is $0.10 as of 2025-07-07. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Syra Health Corp. Class A Common Stock (SYRA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Syra Health Corp. Class A Common Stock stock to fluctuate between $0.03 (low) and $1.71 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-07-07, Syra Health Corp. Class A Common Stock's market cap is $1,146,163, based on 11,939,200 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, Syra Health Corp. Class A Common Stock has a Lower Market-Cap, indicating a difference in performance.

To buy Syra Health Corp. Class A Common Stock (SYRA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SYRA. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $7,982,082 | EPS: -$0.52 | Growth: -13.33%.

Visit https://www.syrahealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $8.37 (2024-02-08) | All-time low: $0.03 (2025-04-21).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

SYRA

prnewswire.com

Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

CARMEL, Ind. , May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site.

SYRA

seekingalpha.com

Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript

Syra Health Corp. (OTC:SYRA) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Corbin Woodhull - Hayden Investor Relations Dr. Deepika Vuppalanchi - Chief Executive Officer Priya Prasad - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen. And welcome to the Syra Health First Quarter 2025 Earnings Conference Call.

SYRA

prnewswire.com

Syra Health Secures $660,000 Population Health Contract Extension

CARMEL, Ind. , March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization.

SYRA

seekingalpha.com

Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript

Syra Health Corp. (NASDAQ:SYRA ) Q4 2024 Earnings Call March 11, 2025 9:00 AM ET Company Participants Brett Maas - Investor Relations Deepika Vuppalanchi - Chair and Chief Executive Officer Priya Prasad - Chief Financial Officer Brett Maas Good morning, everyone, and thank you for joining us for Syra Health's Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct Investor Relations for Syra Health.

SYRA

prnewswire.com

Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind. , March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

SYRA

prnewswire.com

Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee

CARMEL, Ind. , Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee.

SYRA

prnewswire.com

Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University

CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.

SYRA

prnewswire.com

Syra Health Continues to Secure Healthcare Training Contracts

CARMEL, Ind. , Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (Nasdaq: SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener